Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients

Gallbladder cancer (GBC) is a rare, highly aggressive malignancy with a 5-year survival rate of 5–10% in advanced cases, highlighting the need for more effective therapies. The aim of this study was to identify potentially actionable therapeutic targets for GBC. Specimens and clinicopathological dat...

Descripción completa

Detalles Bibliográficos
Autores principales: de Bitter, Tessa J. J., de Reuver, Philip R., de Savornin Lohman, Elise A. J., Kroeze, Leonie I., Vink-Börger, Marianne E., van Vliet, Shannon, Simmer, Femke, von Rhein, Daniel, Jansen, Erik A. M., Verheij, Joanne, van Herpen, Carla M. L., Nagtegaal, Iris D., Ligtenberg, Marjolijn J. L., van der Post, Rachel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637208/
https://www.ncbi.nlm.nih.gov/pubmed/36335173
http://dx.doi.org/10.1038/s41698-022-00327-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637208/
https://www.ncbi.nlm.nih.gov/pubmed/36335173
http://dx.doi.org/10.1038/s41698-022-00327-y

Ejemplares similares